Intermittent Versus Daily Liraglutide: Equivalent Metabolic Efficacy With Reduced Gastrointestinal and Biliary Adverse Effects in Diet-Induced Obese Mice
Intermittent Versus Daily Liraglutide: Equivalent Metabolic Efficacy With Reduced Gastrointestinal and Biliary Adverse Effects in Diet-Induced Obese Mice. // Canadian Journal of Diabetes. – URL: https://www.sciencedirect.com/science/article/pii/S1499267126002832?dgcid=rss_sd_all
Intermittent Versus Daily Liraglutide: Equivalent Metabolic Efficacy With Reduced Gastrointestinal and Biliary Adverse Effects in Diet-Induced Obese Mice. Canadian Journal of Diabetes. https://www.sciencedirect.com/science/article/pii/S1499267126002832?dgcid=rss_sd_all
“Intermittent Versus Daily Liraglutide: Equivalent Metabolic Efficacy With Reduced Gastrointestinal and Biliary Adverse Effects in Diet-Induced Obese Mice.” Canadian Journal of Diabetes.
@article{article97630,
title = {Intermittent Versus Daily Liraglutide: Equivalent Metabolic Efficacy With Reduced Gastrointestinal and Biliary Adverse Effects in Diet-Induced Obese Mice},
journal = {Canadian Journal of Diabetes},
url = {https://www.sciencedirect.com/science/article/pii/S1499267126002832?dgcid=rss_sd_all}
}
Abstract Background Macrophage polarisation plays a crucial role in sepsis‐associated inflammatory responses; however, the underlying molecular regulatory mechanisms remain to be further explored. Aim This study aimed to explore the...